Date: June 4-5

Location: New York City

Cannabis Means Business, formerly CWCBEXPO, is proud to announce the New York Global Edition of its premiere business-to-business (“B2B”) cannabis conference. Scheduled for June 4-5 at the Javits Convention Center in New York City, this expo will offer attendees an opportunity to get hands-on with cannabis technology, hear from a fantastic line-up of speakers, network, and forge business deals with leading entrepreneurs in the space.

Some of the speakers will include cannabis entrepreneurs, policymakers, and celebrity advocates, all of whom will share insights that are shaping the industry’s future and would be integral to growing attendees’ businesses. The event’s experience is second to none, with attendees interacting in person with pioneers in the industry, regulatory experts, and other successful entrepreneurs who are significantly shaping the future of cannabis with proven strategies.

Cannabis Means Business has held this expo consistently since 2015. Over the years, it has been lauded for its incredible networking opportunities for attendees. In addition, it has been praised for the quality of insights and information shared throughout the event, with some attendees referring to it as a “firehose of information for anybody fortunate enough to show up.”

There will be pre-show workshops on June 3, and the main event will kick off officially on June 4 with the main expo and conference, as well as the O2VAPE Industry yacht party. The last day will feature another expo, conference, and a Women In Cannabis business luncheon. 61% of attendees are expected to be decision-makers for their organizations, 70% are expected to be well-established cannabis professionals, and 75% will represent the East Coast cannabis business.

• The pre-show workshops and rooftop party will be held on June 3, 2025.
• The Expo & Conference & O2VAPE Industry Yacht Party will be held on June 4
• The Expo & Conference & Women in Cannabis Business Luncheon will be held on June 5

The Cannabis Means Business Conference & Expo is a must-attend for anyone in this space. With a track record spanning over a decade, this event offers value to each attendee and exhibitor. It also offers a platform where, collectively, attendees can shape the industry for the better and scale it to much higher heights.

To learn more, please visit https://ibn.fm/ZbwdA

• Investing in clean technologies not only benefits the environment but also enhances operational efficiency and cost effectiveness.
• In its 2024 full-year and fourth-quarter financial results, Vivakor reported remarkable growth, with Q4 revenue increasing 201% YOY.
• Other key milestones for the company included the completion of additional gathering lines and the acquisition of Endeavor Entities.

In an era where environmental sustainability has become a global priority, few industries face more scrutiny than oil and gas. As governments, consumers and investors demand cleaner practices and corporate accountability, companies are being urged to innovate and adapt—or risk falling behind. Vivakor (NASDAQ: VIVK), a vertically integrated energy infrastructure and environmental services company, has taken up this challenge with remarkable success. Focused on transportation, storage, reuse and remediation of oilfield fluids and waste, Vivakor is proving that environmental responsibility and profitability are not mutually exclusive.

The oil and gas industry has historically been a significant contributor to greenhouse gas emissions. However, advancements in clean technology offer pathways to reduce this environmental impact. For instance, a report by Rystad Energy indicates that electrifying oil and gas production facilities can cut emissions by more than 80% (https://ibn.fm/uqGGb). Moreover, the International Energy Agency notes that the oil and gas sector is involved in 90% of current carbon capture, utilization and storage (“CCUS”) capacity, highlighting the industry’s potential role in achieving net-zero emissions (https://ibn.fm/yLhVq).

Investing in clean technologies not only benefits the environment but also enhances operational efficiency and cost effectiveness. The National Renewable Energy Laboratory reports that “incorporating clean energy technologies and otherwise reducing the amount of fossil fuels used in petroleum production, transportation and refining processes has the potential to decrease both energy costs and greenhouse gas emissions, as well as to preserve oil and gas resources for their highest value uses (https://ibn.fm/DOFPc). These findings suggest that environmentally responsible companies are not just engaging in ethical practices—they are also positioning themselves to outperform in the marketplace.

Vivakor’s recent performance illustrates the validity of this business model. In its 2024 full-year and fourth-quarter financial results, the company reported remarkable growth, with fourth-quarter revenue increasing 201% year-over-year to $41.7 million (https://ibn.fm/oSYGC). These results pushed the company into a projected $160 million annualized revenue run-rate entering 2025, signaling robust operational momentum. This growth was achieved while staying true to Vivakor’s mission of environmental remediation and oilfield waste reuse, two objectives often seen as at odds in traditional models but fully aligned in Vivakor’s approach.

Another key milestone for the company includes the completion of additional gathering lines connected to its Omega Pipeline System in Blaine County, Oklahoma. This project, which consists of two new gathering lines, is expected to bring immediate incremental customer volumes from connected oil production.

“The Omega Pipeline System is an approximately 40-mile crude oil gathering and shuttle pipeline system that serves the STACK play in Oklahoma’s Anadarko Basin,” the company reported. “It is supported by acreage dedications from key producer and marketing customers, and is connected to the Cushing, Oklahoma, storage and trading hub via the Plains STACK Pipeline. The Omega Pipeline System’s operations are complemented by and integrated with a fleet of approximately two dozen trucks supporting additional incremental volumes from customers.”

In addition, the company has closed on the acquisition of Endeavor Entities, which includes Endeavor Crude LLC, Meridian Equipment Leasing LLC, Equipment Transport LLC, and Silver Fuels Processing LLC, as well as their subsidiaries (https://ibn.fm/UJx2u). This means that Vivakor now owns one of the largest combined fleets of oilfield services in the continental United States.

“Thanks to the support of our shareholders, lenders, business partners, operating and management teams and board of directors, Vivakor had a highly successful 2024, expanding our business organically and through acquisitions, highlighted with the closing of the acquisition of the Endeavor Entities,” said Vivakor CEO James Ballengee. “The Vivakor team has been, and continues to, work tirelessly to fully integrate and improve efficiencies from the business combination with those entities, and I couldn’t be more pleased with the results.

“This past year was transformative for our company and a testament to our evolution as a diversified infrastructure company, with midstream assets in logistics, gathering and storage, as well as sustainable assets in environmental services, remediation and processing solutions,” Ballengee continued. “In gathering and storage, Vivakor moves over 300,000 barrels/month through various assets. In logistics, Vivakor owns and operates over 165 crude oil transportation units in every major domestic oil production basin and over 105 water transportation trucks in south and west Texas. In environmental services, Vivakor’s technology is the only approved recycling processing center (‘RPC’) approved by the Kuwait Oil Company to successfully reduce oil concentration in soil to less than 0.5%.

“By maintaining a strong focus on financial responsibility and operational efficiency, we aim to maximize shareholder value, while advancing our growth mission to expand organically and through acquisitions in 2025 and thereafter,” he concluded.

Looking forward, Vivakor is focused on expanding its environmental services segment, investing in infrastructure that enhances waste oil processing and advancing technologies that reduce emissions and environmental impact. By positioning itself at the intersection of energy production and environmental innovation, the company is poised to play a vital role in the sustainable-energy landscape of the future.

As sustainability continues to influence policy decisions, investment flows and consumer preferences, companies that adopt proactive environmental strategies are likely to thrive. Vivakor exemplifies this shift. Through strategic acquisitions, technological integration and a deep commitment to conscious growth, the company has not only adapted to the pressures of a changing world, but it is also actively shaping a cleaner, more resilient future for the energy sector.

For more information, visit the company’s website at https://vivakor.com.

NOTE TO INVESTORS: The latest news and updates relating to VIVK are available in the company’s newsroom at https://ibn.fm/VIVK

• Newton Golf reports three-figure revenue growth in first quarter of 2025.
• Newton Motion shaft adoption has surpassed 30 professionals.
• Company’s revenue guidance for 2025 is forecast to range between $6.5 and $7 million.

With the launch of its newest shaft family, Newton Golf Company (NASDAQ: NWTG) is seeing triple-figure year-over-year revenue growth, according to the company’s latest financial numbers (https://ibn.fm/hAQWB). The company released its financial report for Q1 2025, noting that revenue had increased an impressive 246% during the first three months of the year.

“We are very pleased with our first-quarter results, especially given that it is typically the offseason for golf,” said Newton Golf CEO Greg Campbell. “When we launched the Newton Motion shaft, our goal was to engineer performance that speaks for itself. The fact that more than 30 professionals are now using Newton shafts across major tours — and that eight of those joined in Q1 — validates both the technology and our direction. We’re just getting started. Demand for our Fast Motion shaft has exceeded expectations, and we are ramping up production to keep pace.”

According to the company’s report, financial highlights for first quarter 2025 include revenue of $1.2 million, up from $350,000 in Q1 2024; an increase in gross profit of 348%, totaling $852,000, up from $190,000 in 2024; and gross margin reaching 70%, up from 54% a year ago. In addition, the report noted that net loss for the company decreased to $0.5 million, or $0.55 per share, compared to $1.2 million, or $24.85 per share in Q1 2024; the company reported cash and cash equivalents of $5.9 million as of March 31, 2025.

Perhaps most exciting for the company was the news that Newton Motion shaft adoption has surpassed 30 professionals, with eight new players joining across PGA TOUR Champions, LPGA, Korn Ferry and PGA TOUR events during the quarter. Other business highlights from the quarterly report included shaft sales growth of 314% year over year and the opportunity to showcase the company’s full product lineup at the 2025 PGA Show.

The quarterly report also noted the company’s growing international reach. Newton Golf signed distribution agreements with two of Japan’s largest golf retailers, and expanded product testing and engagement with club fitting leaders in Europe and North America.

In addition, the Q1 report noted the company’s revenue guidance for 2025, which is forecast to range between $6.5 and $7 million, representing continued strong growth from 2024. “We continue to execute with discipline and focus,” Campbell stated. “The 246% year-over-year revenue growth reflects strong demand, expanding distribution and improving unit economics.

“As we look ahead to the rest of 2025, our focus remains on expansion—new products, new markets, and continued tour validation,” Campbell continued. “We believe Newton’s trajectory is being driven by something deeper than hype. It’s being driven by results, by performance, and by trust on tour. And we’re building for the long-term.”

For more information, visit www.NewtonGolfCo.com.

NOTE TO INVESTORS: The latest news and updates relating to NWTG are available in the company’s newsroom at https://ibn.fm/NWTG

• Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with Universal Capital.
• Combined with a prior strategic investment, for which a financing term sheet has also been signed, the total financing investment, assuming both are closed, represents an expected $10.3 million for HOPE acquisition funding, supporting initial acquisitions of Dura Medical, Kadima, and NeuroSpa clinics.
• The expanding HOPE clinic network will deliver neuroplastic therapies for depression and PTSD, including ketamine and TMS.
• NRx continues regulatory progress for NRX-100 (IV ketamine) and NRX-101 (oral bipolar depression therapy).
• The FDA waived NRx’s $4.3 million drug application fee, and patents could protect NRX-100 through 2045.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, is advancing its twin strategy of expanding a nationwide mental health clinic network while progressing toward FDA approval of its NMDA-based therapies for suicidal depression and bipolar disorder.

The company’s wholly owned subsidiary, HOPE Therapeutics, Inc., a medical and technology-driven company, has signed a term sheet for $7.8 million in debt financing with Universal Capital, LLC (https://ibn.fm/tZzIa). The funds will support HOPE’s clinic acquisition strategy, starting with the previously announced acquisitions of Dura Medical, Kadima Neuropsychiatry Institute, and NeuroSpa TMS Holdings. Together with a separate strategic investment, for which a financing term sheet was signed earlier, HOPE expects to deploy $10.3 million in acquisition capital in the near term, once both agreements are closed.

The clinics will provide interventional psychiatric care focused on neuroplastic therapies like transcranial magnetic stimulation (“TMS”) and intravenous ketamine. These approaches are increasingly used to treat conditions including major depressive disorder, PTSD, and suicidality, offering alternatives to traditional pharmacological treatments.

The acquired clinics are expected to represent roughly $15 million in pro forma revenue for 2025. NRx has also entered talks with four additional clinical entities that could add another $20 million in revenue potential. Management’s stated goal is to scale to $100 million in forward-looking pro forma revenue by year-end.

HOPE Therapeutics has already begun serving veterans through VA contracts, with potential for significant expansion as more clinics come online. U.S. health officials, including the Secretary of Health and Human Services and the VA Secretary, have publicly emphasized the importance of psychedelic and neuroplastic treatments in addressing the nation’s suicide crisis.

HOPE’s expansion takes place as NRx moves closer to FDA approval for its proprietary ketamine formulation, NRX-100. The drug, a preservative-free IV ketamine therapy for suicidal depression, completed the stability and sterility testing needed for its New Drug Application (“NDA”). The NDA is on track to be filed in Q2 2025. The FDA has granted a waiver for the $4.3 million submission fee for NRX-100, and has previously assigned Fast Track Designation to the drug, according to the company’s Q1 financial results and corporate update (https://ibn.fm/cN2Nh).

In May, NRx filed a U.S. patent application for NRX-100, which may offer protection through 2045. The drug is designed to exclude benzethonium chloride, a preservative with known neurotoxicity, making it potentially the only FDA-approved IV ketamine without this additive. The company also announced development of HTX-100, a pH-neutral subcutaneous ketamine formulation, targeting broader outpatient use by eliminating the current formulation’s acidity and associated side effects.

The broader market opportunity for NRX-100 is substantial. Suicidal depression affects millions in the U.S. and is estimated to represent a $3 billion addressable market. 

In parallel, the company is advancing NRX-101, an oral therapy for bipolar depression with suicidality or akathisia. The drug has shown efficacy in late-stage trials and has already received Breakthrough Therapy Designation. A filing for accelerated approval is expected later in 2025, with a PDUFA date anticipated by year-end.

NRx presented these updates at the recent Wall Street Conference in Palm Beach, Florida, where the company was one of six featured presenters. Over 1,000 attendees representing more than $1 trillion in capital were present for the presentation given by CEO, Founder, and Chairman Jonathan Javitt, MD, MPH, underscoring investor interest in the company’s progress (https://ibn.fm/QJwZ0).

Commenting on the recent updates, Javitt underlined that the company’s 2024 momentum continued into 2025, as it has advanced regulatory filings for NRX-100 and NRX-101 and advanced commercial opportunity with potential new IP protection for NRX-100, now added to the company’s already robust NMDA IP portfolio. “We also took meaningful steps toward realizing our vision for HOPE Therapeutics as a national network of interventional psychiatry clinics—beginning with the announcements on the planned acquisition of Kadima, Dura Medical, and Neurospa TMS,” said Javitt. “These accomplishments reflect our team’s dedication to advancing mental health innovation and delivering life-saving treatments to patients in urgent need.”

For more information, visit the company’s website at www.NRxPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to NRXP are available in the company’s newsroom at https://ibn.fm/NRXP

Ecuador is on the verge of a mine-building surge, as President Daniel Noboa’s reelection coincides with high metals prices and a handful of projects ready for development.

He will start his second term on May 24 on the brink of a mining bonanza, with six projects at the development stage representing at least US$10 billion in investment slated for construction decisions during the 2025-2029 presidential term.

During his current term, truncated to about 18 months as he is completing the term of the previous incumbent, Guillermo Lasso, Noboa has been an advocate of growing Ecuador’s mining sector to boost employment, public coffers and diversify the economy. The country’s needs are many and Noboa recognizes that Ecuador needs the investment and wealth generation that mining can bring.

In a busy 18 months, his administration has overseen projects obtaining permits and signed tax stability agreements with several companies. It has also successfully negotiated a free trade agreement (“FTA”) with Canada, which includes an investment chapter, although without a mining-specific chapter.

Of particular note is that Noboa won in the mining provinces of Azuay, Bolivar, Cotopaxi, El Oro, Esmeraldas, Imbabura, Morona Santiago and Loja.

The positive scenario in Ecuador was quickly recognized by China’s mining giant CMOC (~US$21 billion market cap), which agreed to buy gold-copper developer Lumina Gold for C$581 million at a 71% premium in April for its Cangrejos deposit. China’s Jiangxi Copper also increased its investment into another Ecuador copper-gold developer, Solgold, becoming its largest shareholder with a 12% stake.

International lending agencies such as the World Bank (“WB”) and the International Monetary Fund (“IMF”) are keen for Ecuador to develop its natural resources and presumably be less dependent on loans. “WB and IMF both recently said that Ecuador should drive mining development,” Maria Eulalia Silva, president of Ecuador’s Mining Chamber said recently.

Silva said that Ecuador is no longer naïve when it comes to mining and the people can draw on the positive experience the country has had through the successful developments of Lundin Gold’s Fruta del Norte gold mine and Ecuacorriente’s Mirador copper mine, which both started production in 2019. The development of these two mines have seen Ecuador’s mining exports soar to become its fourth largest export, accelerating from US$275 million in 2018 to US$3.3B in 2023. Higher metal prices and more projects will see these continue to climb.

Silvercorp’s El Domo Project

Leading the charge to develop Ecuador’s next mine is Silvercorp Metals Inc. (TSX: SVM) (NYSE-A: SVM), whose El Domo project, which it will develop with local partner Salazar Resources (TSX.V: SRL), is poised to become Ecuador’s first new mine in nearly a decade. This was one of the projects that received its final permits from the Noboa administration in 2024, with the partners aiming to bring it into production by the end of 2026.

Located 150 km northeast of Guayaquil, the US$241-million development has a 2021 feasibility study that outlined a 10-year operation to produce an annual average of 24Mlb of copper, 26,000oz of gold, 26Mlb of zinc, 488,000oz of silver and 0.9Mlb of lead at an all-in sustaining cost of US$1.26/lb of copper equivalent.

El Domo, which was discovered by Salazar in 2008, hosts proven and probable reserves of 6.5 million tonnes grading 1.93% copper, 2.52g/t of gold, 2.49% zinc, 45.7g/t of silver and 0.25% lead, which makes it among the highest-grade copper-gold projects globally.

El Domo mine construction is fully financed through a US$175.5-million streaming deal that the previous owner, Adventus Mining, secured from Wheaton Precious Metals (TSX: WPM) (NYSE: WPM) (LSE: WPM), along with Silvercorp’s strong balance sheet, which has US$355 million in cash as of December 31, 2024.

Silvercorp, a proven mine builder and operator with a track record of success in China developing and operating low-cost mines, is now applying the same disciplined capital allocation, results-driven approach to the El Domo Project. In April, the company announced the budget for El Domo’s development of US$240.5 million, 3% below the US$247.6 million estimate in the 2021 feasibility, at a time when developers are battling inflation. The cost reduction stems from mine design optimization, lower equipment costs, and a unit-cost contract bidding strategy, resulting in US$32.6 million in direct cost saving. The latest budget also includes a larger contingency of US$31.9 million, up from US$22.0 million, providing additional flexibility.

Silvercorp’s ability to execute efficiently is not theoretical, it has already delivered. At one of its operations in China, the company completed a new tailings storage facility for just US$28 million, coming in well below the original $38 million budget. Silvercorp has also successfully carried out a mill expansion of comparable scale to El Domo on time and under budget. These accomplishments reflect a repeatable, disciplined execution model that Silvercorp is now bringing to Ecuador.

Construction is now underway with pit stripping and plant construction scheduled to commence in Q3 2025, and commissioning targeted in December 2026. Silvercorp has advanced detailed engineering for the tailings storage facility (“TSF”), saprolite waste dump, and water management system, and optimized designs for the open pit mine and process plant, and site access. It has also secured grid power through a powerline contract with the state-owned power company CNEL and is advancing on permitting and sourcing for standby diesel power generators for the dry season, when hydropower will be less available.

With work well underway and momentum building, Silvercorp is positioned to move rapidly through the development process to bring Ecuador’s next mine into production early in President Noboa’s second term at a time when the country needs mining most.

For more information about Silvercorp Metals, please visit silvercorpmetals.com/welcome.

Third-Party Content Disclaimer

The IBN website may contain third-party content articles and other content submitted by third parties, including articles submitted through the IBN Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of IBN or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and IBN does not endorse, guarantee or make representations concerning the accuracy and completeness of any third-party content. You acknowledge that by IBN providing you with this internet portal that makes accessible to you the ability to view third-party content through the IBN site, IBN does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. IBN expressly disclaims liability relating to such third-party content. IBN and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, IBN reserves the right to remove third-party content at any time in its sole discretion. By viewing this third-party content, you acknowledge that you have viewed, read fully, accepted and agreed to all terms of the disclaimer at https://IBN.fm/Disclaimer.

• Newton Golf’s new Fast Motion shaft exemplifies how a company can use innovation to sharpen its competitive edge.
• The Fast Motion shaft incorporates several proprietary technologies that Newton Golf has developed over time.
• This product launch is timely, as the golf equipment market continues to experience growth, driven by a surge in participation and a demand for premium gear.

Innovation has long been a driving force behind business growth, market disruption and brand longevity across nearly every sector of the global economy. In the world of sports equipment, few areas are as ripe for innovation as golf, where players are always seeking performance gains. Newton Golf Company (NASDAQ: NWTG) has seized this opportunity with the launch of its latest product: the Fast Motion shaft family (https://ibn.fm/9Z5jh). With this innovative new offering, the company aims to redefine performance standards and capitalize on the growing appetite for cutting-edge golf technology.

Companies that embrace forward-thinking ideas and invest in product development often find themselves ahead of the curve—delivering better solutions, improving customer satisfaction and achieving long-term profitability. The significance of innovation in business is underscored by numerous studies. According to McKinsey, 84% of executives believe innovation is critical for growth, and companies that prioritize innovation are 50% more likely to report market leadership. Furthermore, organizations that foster a culture of innovation are three times more likely to outperform competitors (https://ibn.fm/OSC6w).

Newton Golf’s new Fast Motion shaft exemplifies how a company can use innovation to sharpen its competitive edge. This latest addition to the Newton shaft lineup introduces a lighter-weight, high-performance alternative to existing models. Designed for golfers seeking increased distance and higher swing speeds, the Fast Motion shaft delivers these enhancements without compromising control or accuracy. In doing so, Newton continues to build on its strong reputation for combining advanced engineering with a deep understanding of player needs.

The Fast Motion shaft incorporates several proprietary technologies that Newton Golf has developed over time. These include the following:

• Elongated Bend Profile, which contributes to a smooth, consistent flex throughout the swing
• Kinetic Energy Storage, which optimizes energy transfer from the shaft to the ball
• Symmetry 360 Construction, providing stability in all directions
• Variable Bend Profile, which fine-tunes the release for better feel and control

With the Fast Motion shaft, Newton builds on these foundational technologies while introducing weight reduction through the use of ultralight, high-modulus Toray carbon fibers—materials known for their extraordinary strength-to-weight ratio and frequently used in aerospace and Formula 1 applications.

This product launch is timely, as the golf equipment market continues to experience growth, driven by a surge in participation and a demand for premium gear. According to the National Golf Foundation, more than 28.1 million people played golf on a course in the United States in 2024 — the highest number in over a decade (https://ibn.fm/kDzfs). The demand for quality equipment, especially in the aftermarket shaft category, has surged accordingly. Golfers of all skill levels are now investing in advanced gear that can help improve their game, and innovation is at the heart of that trend.

For Newton Golf, innovation has translated into tangible results. The company reported an 887% revenue increase in fiscal year 2024, largely driven by strong sales of its first-generation shaft lineup (https://ibn.fm/IzgnH). With the introduction of the Fast Motion shaft, Newton is poised to build on this momentum, targeting golfers who are eager to push the boundaries of performance while maintaining a high level of playability. The Fast Motion shaft was launched with widespread availability online and at fitting locations across the country, ensuring accessibility for players at all levels.

Newton’s innovative spirit is deeply rooted in its mission to “empower golfers with scientifically advanced tools that maximize consistency and accuracy, ensuring every swing is backed by the laws of physics.” The company’s product philosophy is based on rigorous testing, continuous refinement and a commitment to meeting the specific needs of today’s golfer. The Fast Motion shaft reflects these principles, demonstrating that innovation is not simply about newness but also delivering measurable improvements.

As competition in the golf equipment market intensifies, Newton Golf’s focus on innovation ensures that it won’t just keep pace—it will lead. The Fast Motion shaft is more than just a new product; it represents a larger vision for the company, one that prioritizes technological advancement, player-centric design, and a relentless pursuit of performance. In doing so, Newton Golf is carving out a position not only as a supplier of premium golf components but as an innovation leader in the industry.

For more information, visit www.NewtonGolfCo.com.

NOTE TO INVESTORS: The latest news and updates relating to NWTG are available in the company’s newsroom at https://ibn.fm/NWTG

• Total assets rose to $194 million as of March 31, 2025, as compared to the end of the last fiscal year, following a key acquisition.
• Revenue from the company’s independent power producer segment grew from $0.3 million to $6.6 million.
• This reflects the company’s focus on long-term income-generating assets, versus short-term engineering, procurement, and construction/project sales.
• During the third quarter, SolarBank executed several operational milestones that align with this longer-term focus.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., posted fiscal third-quarter results reflecting a sharp increase in total assets with a notable shift in its revenue model.

The company reported a 395% increase in assets, rising from $39.2 million as of June 30, 2024, to $194 million by March 31, 2025. This jump was primarily driven by the acquisition of Solar Flow-Through Funds Ltd., a strategic move that significantly expanded SolarBank’s asset base and supports its evolving business model as outlined in the Q3 update (https://ibn.fm/YIsC8).

SolarBank is transitioning from a model focused on up-front Engineering, Procurement, and Construction (“EPC”) and project sales, toward building a portfolio of long-term income-generating assets through its Independent Power Producer (“IPP”) segment. While this shift may reduce short-term revenue, the long-term aim is a stable and recurring revenue stream.

Evidence of this transition can be seen in the company’s IPP revenue, which rose to $6.6 million during the nine-month period ended March 31, up from just $0.3 million in the previous year.

During the third quarter, SolarBank executed several operational milestones. The company sold its 3.26 MW Camillus Solar Project to Solar Advocate Development LLC for $7.3 million USD. Though the project sale represents immediate revenue, it also reflects SolarBank’s role in originating and maturing assets for its pipeline.

It also broke ground on its first battery energy storage system (“BESS”) project in Ontario. The construction is backed by a $25.8 million project finance facility from the Royal Bank of Canada, marking a key step in its expansion into hybrid energy storage solutions.

In the U.S., SolarBank announced a partnership with Viridi, a provider of fail-safe BESS technology, for the development of a 3.06 MW solar project with a 1.2 MWh BESS component in Buffalo, New York.

The company further disclosed a financing mandate with infrastructure investor CIM Group. The deal could unlock up to $100 million USD in project-based financing for a U.S. solar power portfolio totaling 97 MW. The CIM transaction is expected to be non-dilutive and represents a potential step-change in the scale of SolarBank’s project financing.

This shift toward long-term revenue generation through power production and storage assets is a notable strategy for investors looking beyond traditional solar EPC companies. With growing demand for clean energy and increasing interest in hybrid solutions that include storage, SolarBank is positioning itself to participate more fully in the infrastructure side of the sector.

“SolarBank continues the growth of its independent power producer portfolio. The non-dilutive CIM transaction will provide up to US$100 million in equity capital for projects that will transform SolarBank’s independent power producer asset base, creating long-term revenues for years to come,” said CEO Dr. Richard Lu. “As discussed in prior quarters, this strategy means less short-term revenue from EPC and project sales, but will have the benefit of stable long-term recurring revenues.”

For more information, visit the company’s website at SolarBankCorp.com.

This report contains forward looking information. Please refer to the press release entitled “SolarBank Announces Third Quarter Results” for additional details on the information, risks and assumptions.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

The Cannabis Means Business Conference & Expo will be held on June 4-5, 2025, in New York City as a two-day B2B event. Formerly known as CWBExpo, CMB has been operational since 2015.

CMB highlights include:

• The pre-show workshops and rooftop party will be held on June 3, 2025.
• The Expo & Conference & O2VAPE Industry Yacht Party will be held on June 4
• The Expo & Conference & Women in Cannabis Business Luncheon will be held on June 5

CMB caters to the innovative, business, and creative needs of the vibrant cannabis industry in New York City. It offers tremendous growth and learning opportunities by connecting members of the cannabis community to interact and discover the latest trends and opportunities in the cannabis sector. Experts of global acclaim gather at the CMB events to discuss and share insights on the evolution and challenges faced by the cannabis industry. Participants can connect with the experts to get answers to their queries and expert advice on several topics. Industry stalwarts will conduct sessions to share insights on the latest regulatory and legal complexities. They also suggest viable solutions and effective strategies for the rapidly changing cannabis landscape. Thought leaders, innovators, and industry experts can showcase their knowledge and expertise to a crowd of enthusiasts from the cannabis spectrum.

Whoopi Goldberg, EGOT winner and entrepreneur, will make a special appearance at CMB for a live fireside chat and discuss her new hemp-derived THC mocktail, Whoop-Tea, created in partnership with Pure Genesis. Moderated by CNBC’s Tim Seymour, the conversation will explore Whoopi’s entry into the cannabis beverage space, her wellness vision, and the industry’s explosive growth.

CMB is renowned for providing an unparalleled platform for networking, education, and business development. With an expansive exhibit floor and a diverse slate of industry-leading speakers, CMB attendees can expect an array of educational sessions, workshops, and networking opportunities designed to address the complexities of operating within the regional, national, and global cannabis marketplace.

To learn more, please visit https://ibn.fm/1HdIw.

• Noble Capital Markets Research released a comprehensive analysis of Nicola Mining.
• Nicola distinguishes itself among junior mining companies by combining exploration potential with operational cash flow, report states.
• Noble report also noted the company’s “superb corporate governance,” led by CEO Peter Espig, former 20-year Goldman Sachs banker.

Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF), a junior mining company based in British Columbia, has recently been the focus of a comprehensive analysis by Noble Capital Markets Research (https://ibn.fm/3CDHY). The report gave the company an “Outperform” rating and a 12-month price target of C$0.70 and US$0.50 per share while highlighting Nicola Mining’s diversified asset base and cash-generating operations as key factors supporting this valuation.

“Nicola Mining is a unique junior exploration company because it offers discovery potential through its ownership of its flagship New Craigmont Copper Project, ownership of the Treasure Mountain high-grade silver-lead-zinc mine, a 75% economic interest in the Dominion Creek gold project, along with 100% ownership of the only mill permitted to receive and process material from throughout British Columbia,” the report stated. The company’s Merritt Mill, along with a sand/gravel pit, rock quarry, and ready-mix cement plant, generates cash flow supporting Nicola’s operations and exploration programs, which minimizes the need for dilutive equity issuance.

The New Craigmont Copper Project is noted as Nicola Mining’s flagship asset. Located in the Quesnel Trough, one of Canada’s most prolific copper belts, the project is adjacent to Teck Resources’ Highland Valley Copper Mine, the largest copper mine in Canada. The historic Craigmont Mine, which operated on the property from 1961 to 1982, produced more than 36.75 million tons of ore with an average grade of 1.28% copper, yielding 900 million pounds of copper.

Nicola Mining has completed more than 18,000 meters of diamond drilling, along with extensive geological mapping and surveys. In 2024, the company completed a geophysical survey to define drill targets in the WP, MARB and CAS zones, which were later drilled. Two holes were drilled in the Embayment Zone, expanding the known mineralized areas. Results from the program suggest the potential for copper porphyry systems. The company has finalized targets for the 2025 drilling season, expected to begin in June.

In addition to New Craigmont, Nicola Mining owns 100% of the past-producing Treasure Mountain high-grade silver, lead and zinc underground mine, which has significant exploration potential and an active mining permit.

Nicola Mining’s Merritt Mill is a fully permitted facility capable of processing both gold and silver mill feed via gravity and flotation processes. The mill, along with the company’s sand and gravel pit and rock quarry, provides operational cash flow that supports exploration activities. This diversified revenue stream is seen as a strategic advantage, enabling the company to fund its operations while minimizing shareholder dilution.

The Noble report also noted the company’s “superb corporate governance,” led by CEO Peter Espig. “Espig has had an accomplished career as an investment banker and turnaround specialist and has held executive positions with Goldman Sachs and Olympus Capital,” the report stated. “Nicola benefits from a talented management team and board with relevant experience in mining, geology, and finance.”

Noble Capital Markets’ initiation of coverage on Nicola Mining reflects confidence in the company’s ability to leverage its assets and operational cash flow to advance its exploration projects. The combination of a strong management team, strategic asset portfolio and revenue-generating operations underpins the “Outperform” rating and the price target of C$0.70 and US$0.50 per share.

“Nicola distinguishes itself by offering investors significant discovery and value creation potential through its exploration activities at New Craigmont and Treasure Mountain while generating cash flows from the Merritt Mill, which processes ore from third parties, a sand and gravel pit, rock quarry, and ready-mix cement plant,” the report concluded. “These operations help fund Nicola’s operations and exploration activities while limiting the need to issue dilutive equity. While the flagship New Craigmont Copper Project is the company’s value driver, we think the company’s Treasure Mountain Project represents an opportunity to create value through M&A, divestiture, joint venture, or reopening the mine.”

For more information, visit www.NicolaMining.com.

NOTE TO INVESTORS: The latest news and updates relating to HUSIF are available in the company’s newsroom at https://ibn.fm/HUSIF

• The overuse and misuse of antibiotics have led to the emergence of antibiotic-resistant bacteria, posing a significant threat to public health.
• Soligenix’s SGX943 is a novel broad-spectrum therapy designed to treat bacterial infections without relying on conventional antibiotics.
• Preclinical studies have demonstrated the efficacy of SGX943 in various models of bacterial infection.

In the face of escalating antibiotic resistance, the medical community is urgently seeking alternative treatments for bacterial infections. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is at the forefront of this effort with its development of SGX943 (dusquetide), a novel broad-spectrum therapy designed to combat bacterial infections without relying on traditional antibiotics.

Antibiotics have been a cornerstone of modern medicine, effectively treating a wide range of bacterial infections. However, their overuse and misuse have led to the emergence of antibiotic-resistant bacteria, posing a significant threat to public health. According to the Centers for Disease Control and Prevention (“CDC”), at least 2.8 million people in the United States are infected with antibiotic-resistant bacteria annually, resulting in more than 35,000 deaths (https://ibn.fm/qjibe).

The challenge is compounded by the fact that antibiotics are often specific to certain types of bacteria, and their efficacy can be compromised by resistance mechanisms. Moreover, the development of new antibiotics has not kept pace with the rapid evolution of resistant strains, leaving clinicians with limited options for treatment. Globally, the World Health Organization (“WHO”) has identified antimicrobial resistance as one of the top ten public health threats facing humanity. The situation is dire: if left unaddressed, it is projected that antibiotic resistance could cause 10 million deaths per year by 2050, surpassing cancer as a leading cause of death (https://ibn.fm/vC6MQ).

It is within this context that alternative approaches to bacterial infection treatment have become critically important. Soligenix’s SGX943 represents one such approach that could change the paradigm. SGX943 is a novel broad-spectrum therapy designed to treat bacterial infections without relying on conventional antibiotics (https://ibn.fm/5RJFl). This promising therapy takes a fundamentally different approach by leveraging the body’s innate immune system rather than directly targeting pathogens, offering a powerful new tool in the fight against resistant bacterial infections.

Soligenix’s SGX943 therapy is based on dusquetide, an Innate Defense Regulator (“IDR”) that modulates the body’s immune response rather than directly targeting bacteria. By enhancing the innate immune system, SGX943 promotes the clearance of infections and reduces inflammation, offering a broad-spectrum approach to bacterial infections.

One of the key advantages of SGX943 is its ability to be effective regardless of the bacterial species involved. This means it can be administered before the specific pathogen is identified, providing a timely intervention in acute infections. Additionally, SGX943 can be used in conjunction with existing antibiotics, potentially enhancing their efficacy and mitigating the development of resistance.

Preclinical studies have demonstrated the efficacy of SGX943 in various models of bacterial infection, including those caused by antibiotic-resistant strains. Notably, the therapy has shown promise in treating melioidosis, a serious infection caused by Burkholderia pseudomallei, which is highly resistant to many antibiotics. The U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation to SGX943 for the treatment of melioidosis, recognizing its potential to address an unmet medical need.

The rise of antibiotic-resistant bacteria underscores the critical need for innovative therapies that go beyond traditional antibiotics. Soligenix’s SGX943 offers a novel approach by harnessing the body’s innate immune system to fight infections, providing a versatile and potentially more effective treatment option. As the medical community continues to grapple with the challenges of antibiotic resistance, therapies like SGX943 represent a hopeful advancement in the fight against bacterial infections.

Headquartered in Princeton, New Jersey, Soligenix operates within the medical, biomedical and genetics sector. The company’s portfolio encompasses both specialized biotherapeutics and public health solutions, targeting areas with significant unmet medical needs. Among its leading candidates are HyBryte(TM) (SGX301), a photodynamic therapy for cutaneous T-cell lymphoma (“CTCL”), and SGX942 (dusquetide), designed to address oral mucositis in patients undergoing chemoradiation for head and neck cancer.

For more information, visit www.Soligenix.com.

NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX